Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Schwartz, G.G.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(37)
+
-
Availability
Open access
(24)
+
-
Metadata Only
(13)
+
-
Creation Date
2019
(9)
+
-
2020
(8)
+
-
2022
(7)
+
-
2021
(4)
+
-
2023
(4)
+
-
2014
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(32)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(32)
+
-
Scholarly Publications
(5)
+
-
Topic
acute coronary syndrome
(11)
+
-
alirocumab
(8)
+
-
Alirocumab
(7)
+
-
Acute coronary syndrome
(6)
+
-
cholesterol
(4)
+
-
lipoprotein(a)
(4)
+
-
LDL
(3)
+
-
Low-density lipoprotein cholesterol
(3)
+
-
PCSK9 inhibitor
(3)
+
-
acute coronary syndromes
(3)
+
-
low-density lipoprotein cholesterol
(3)
+
-
major adverse cardiovascular events
(3)
+
-
PCSK9
(2)
+
-
PCSK9 protein
(2)
+
-
peripheral artery disease
(2)
+
-
Show more
Author
Schwartz, G.G.
(37)
+
-
Jukema, J.W.
(36)
+
-
Goodman, S.G.
(33)
+
-
Steg, P.G.
(33)
+
-
Szarek, M.
(33)
+
-
Diaz, R.
(31)
+
-
Bhatt, D.L.
(30)
+
-
Pordy, R.
(30)
+
-
White, H.D.
(30)
+
-
Bittner, V.A.
(29)
+
-
Zeiher, A.M.
(20)
+
-
Harrington, R.A.
(19)
+
-
Roe, M.T.
(16)
+
-
ODYSSEY OUTCOMES Investigators
(15)
+
-
Chiang, C.E.
(14)
+
-
Danchin, N.
(12)
+
-
Fras, Z.
(12)
+
-
Hagstrom, E.
(12)
+
-
Liberopoulos, E.
(12)
+
-
Moriarty, P.M.
(12)
+
-
Parkhomenko, A.
(12)
+
-
Ray, K.K.
(12)
+
-
Reiner, Z.
(12)
+
-
Tse, H.F.
(12)
+
-
Zahger, D.
(12)
+
-
Alings, M.
(11)
+
-
Chua, T.
(11)
+
-
Dilic, M.
(11)
+
-
Dorobantu, M.
(11)
+
-
Drexel, H.
(11)
+
-
Erglis, A.
(11)
+
-
Flores, R.M.C.
(11)
+
-
Halvorsen, S.
(11)
+
-
Hanotin, C.
(11)
+
-
Karpov, Y.
(11)
+
-
Kim, H.S.
(11)
+
-
Kim, S.H.
(11)
+
-
Kimura, T.
(11)
+
-
Lopes, R.D.
(11)
+
-
Lopez-Jaramillo, P.
(11)
+
-
Marx, N.
(11)
+
-
Morais, J.
(11)
+
-
Moryusef, A.
(11)
+
-
Olsson, A.G.
(11)
+
-
Ostadal, P.
(11)
+
-
Pecin, I.
(11)
+
-
Poulsen, S.H.
(11)
+
-
Ristic, A.D.
(11)
+
-
Sinnaeve, P.
(11)
+
-
Sritara, P.
(11)
+
-
Sy, R.G.
(11)
+
-
Tunon, J.
(11)
+
-
Valdovinos, P.C.M.
(11)
+
-
Valgimigli, M.
(11)
+
-
Abrantes, J.A.M.
(10)
+
-
Alexander, J.H.
(10)
+
-
Alexander, K.
(10)
+
-
Allende, J.C.M.
(10)
+
-
Alvarisqueta, A.F.
(10)
+
-
Amuchastegui, M.
(10)
+
-
Armaganijan, L.
(10)
+
-
Arstall, M.A.
(10)
+
-
Aylward, P.E.
(10)
+
-
Bagai, A.
(10)
+
-
Bahit, M.C.
(10)
+
-
Barakovic, F.
(10)
+
-
Barbato, E.
(10)
+
-
Beauloye, C.
(10)
+
-
Berger, R.
(10)
+
-
Berli, M.A.
(10)
+
-
Blumberg, E.D.S.
(10)
+
-
Bodanese, L.C.
(10)
+
-
Bono, J.O.E.
(10)
+
-
Bordonava, A.P.
(10)
+
-
Brasca, D.F.G.
(10)
+
-
Brennan, J.M.
(10)
+
-
Budaj, A.
(10)
+
-
Caccavo, A.
(10)
+
-
Caime, G.D.
(10)
+
-
Carnero, G.S.
(10)
+
-
Carroll, P.A.
(10)
+
-
Cartasegna, L.R.
(10)
+
-
Caruso, O.C.
(10)
+
-
Castadot, M.
(10)
+
-
Cerqueira, M.J.A.G.
(10)
+
-
Cestari, H.G.
(10)
+
-
Chaitman, B.
(10)
+
-
Chumburidze, V.
(10)
+
-
Claeys, M.
(10)
+
-
Clifton, S.
(10)
+
-
Codutti, O.R.
(10)
+
-
Collins, N.
(10)
+
-
Colombo, H.R.
(10)
+
-
Colquhoun, D.
(10)
+
-
Convens, C.
(10)
+
-
Cools, F.
(10)
+
-
Coverdale, S.G.M.
(10)
+
-
Dalby, A.J.
(10)
+
-
DeVore, A.D.
(10)
+
-
Deloatch, S.
(10)
+
-
Dickey, S.
(10)
+
-
Diepen, S.F.P. van
(10)
+
-
Dombrowski, K.
(10)
+
-
Dran, R.D.
(10)
+
-
Ducrocq, G.
(10)
+
-
Duda, N.
(10)
+
-
Dujardin, K.
(10)
+
-
Durak-Nalbantic, A.
(10)
+
-
Duran, R.O.G.
(10)
+
-
Duronto, E.A.
(10)
+
-
Eapen, Z.
(10)
+
-
Edelberg, J.M.
(10)
+
-
Eliaschewitz, F.G.
(10)
+
-
Endsley, P.
(10)
+
-
Eppinger, A.
(10)
+
-
Faes, D.
(10)
+
-
Fazlibegovic, E.
(10)
+
-
Flores, R.E.O.
(10)
+
-
Garrahy, P.J.
(10)
+
-
Garrido, M.
(10)
+
-
Show more
Language
en
(37)
+
-
Search results
(1 - 24 of 37)
Pages
1
2
›
››
show grid
show list
save search
Relating lipoprotein(a) concentrations to cardiovascular event risk after acute coronary syndrome
Lipoprotein(a) and the effect of alirocumab on revascularization after acute coronary syndrome
Effect of alirocumab on cataracts in patients with acute coronary syndromes (vol 23, 279, 2023)
Effect of alirocumab on cataracts in patients with acute coronary syndromes
Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-alpha/gamma agonist aleglitazar
Alirocumab and cardiovascular outcomes in patients with previous myocardial infarction
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes
Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome
Alirocumab after acute coronary syndrome in patients with a history of heart failure
Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol
Relation of lipoprotein(a) levels to incident type 2 diabetes and modification by alirocumab treatment
Clinical efficacy and safety of alirocumab after acute coronary syndrome according to achieved level of low-density lipoprotein cholesterol a propensity score-matched analysis of the ODYSSEY OUTCOMES trial
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age
Peripheral artery disease and venous thromboembolic events after acute coronary syndrome role of lipoprotein(a) and modification aby alirocumab
Cost-effectiveness of alirocumab in patients with acute coronary syndromes the ODYSSEY OUTCOMES trial
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
REPLY: alirocumab in polyvascular atherosclerotic disease
Pages
1
2
›
››